Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Morard

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Revue Medicale Suisse|October 11, 2005
[New aspect in the treatment of chronic hepatis B]I Morard, E Giostra, F Negro
Revue Medicale Suisse|February 28, 2012
[Antibiotic prophylaxis in liver cirrhosis]S Restellini, M Nendaz, I Morard
Hepato-Gastroenterology|May 31, 2001
Procalcitonin is not an accurate marker of spontaneous bacterial peritonitis in patients with cirrhosisL Spahr, I Morard, A Hadengue, et al.
Revue Medicale Suisse|May 14, 2008
[Terbinafine induced hepatitis with persistent cholestasis]G Gendre, T Buclin, I Morard, et al.
Revue Medicale Suisse|September 30, 2006
[Management of patients after liver transplantation]A De Gottardi, I Morard, J Dumortier, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|January 16, 2009
Pegylated interferon-alpha2a/ribavirin treatment of recurrent hepatitis C after liver transplantationS Dinges, I Morard, M Heim, et al.
Swiss Surgery = Schweizer Chirurgie = Chirurgie Suisse = Chirurgia Svizzera|November 7, 2003
Adult-to-adult living-donor liver transplantation. A summary of current status and an outline of the program in GenevaP Majno, G Mentha, Th Berney, et al.
Revue Medicale Suisse|March 11, 2011
[Liver transplantation]G Mentha, P Majno, I Morard, et al.
Acta Gastro-Enterologica Belgica|August 3, 2004
Treatment of hepatocellular carcinoma at the dawn of the third millennium: liver transplantation and its alternativesP Majno, G Mentha, E Giostra, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 13, 2012
A randomized, controlled study to assess the conversion from calcineurin-inhibitors to everolimus after liver transplantation--PROTECTL Fischer, J Klempnauer, S Beckebaum, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Revue Medicale Suisse|October 11, 2005
[New aspect in the treatment of chronic hepatis B]I Morard, E Giostra, F Negro
Revue Medicale Suisse|February 28, 2012
[Antibiotic prophylaxis in liver cirrhosis]S Restellini, M Nendaz, I Morard
Hepato-Gastroenterology|May 31, 2001
Procalcitonin is not an accurate marker of spontaneous bacterial peritonitis in patients with cirrhosisL Spahr, I Morard, A Hadengue, et al.
Revue Medicale Suisse|May 14, 2008
[Terbinafine induced hepatitis with persistent cholestasis]G Gendre, T Buclin, I Morard, et al.
Revue Medicale Suisse|September 30, 2006
[Management of patients after liver transplantation]A De Gottardi, I Morard, J Dumortier, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|January 16, 2009
Pegylated interferon-alpha2a/ribavirin treatment of recurrent hepatitis C after liver transplantationS Dinges, I Morard, M Heim, et al.
Swiss Surgery = Schweizer Chirurgie = Chirurgie Suisse = Chirurgia Svizzera|November 7, 2003
Adult-to-adult living-donor liver transplantation. A summary of current status and an outline of the program in GenevaP Majno, G Mentha, Th Berney, et al.
Revue Medicale Suisse|March 11, 2011
[Liver transplantation]G Mentha, P Majno, I Morard, et al.
Acta Gastro-Enterologica Belgica|August 3, 2004
Treatment of hepatocellular carcinoma at the dawn of the third millennium: liver transplantation and its alternativesP Majno, G Mentha, E Giostra, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 13, 2012
A randomized, controlled study to assess the conversion from calcineurin-inhibitors to everolimus after liver transplantation--PROTECTL Fischer, J Klempnauer, S Beckebaum, et al.
Pageof 1